Read more
At a time when the human genome has been sequenced advances in the life sciences seem to have great potential for human health, industry and the environment throughout Central and Eastern Europe (CEE). Still, for some, potential risks and ethical dilemmas remain, surrounding issues such as the appropriate use of GM crops, stem cells, genetic information, the nature of intellectual property and other challenges that come with EU accession. This book is the first of its kind to bring together experts from across Europe to explore the landscape of current life science policy and industrial development in CEE, including implications for economies, regulatory and legal frameworks, health care, ethics and human rights. It will be essential reading for researchers and students in science and technology studies, development, sociology, politics and law, and those interested in life science development in transition economies.
List of contents
1 Human Life Science and Agricultural Biotechnology in Transition: An Introduction.- 2 Biotechnology in Central and Eastern Europe: An Overview of Performance and Policy Systems.- 3 Citizen Participation in Controversial EU Research Policies? The Debate on Human Embryonic Stem Cell Research within the 6th Framework Programme.- 4 The Politics of Human Embryo Research in Poland.- 5 Legal Ambiguities Concerning Medical Genetics in Poland - Searching For a Common Ground.-6 Managing Trust and Risk in New Biotechnologies: The Case of Population Genome Project and Organ Transplantation in Latvia.-7 Social Trenches in the GM Food Battlefield: Experiences of a Survey Series in Hungary.- 8 Coping Strategies and System Adaptation of Agricultural Biotechnology Research in Hungary.- 9 Contested Agro-Technological Futures: The GMO and the Construction of European Space.- 10 Final Remarks.
Summary
At a time when the human genome has been sequenced advances in the life sciences seem to have great potential for human health, industry and the environment throughout Central and Eastern Europe (CEE). Still, for some, potential risks and ethical dilemmas remain, surrounding issues such as the appropriate use of GM crops, stem cells, genetic information, the nature of intellectual property and other challenges that come with EU accession. This book is the first of its kind to bring together experts from across Europe to explore the landscape of current life science policy and industrial development in CEE, including implications for economies, regulatory and legal frameworks, health care, ethics and human rights. It will be essential reading for researchers and students in science and technology studies, development, sociology, politics and law, and those interested in life science development in transition economies.
